SLC4A7
Basic information
Region (hg38): 3:27372723-27484420
Previous symbols: [ "SLC4A6" ]
Links
Phenotypes
GenCC
Source:
- cone-rod dystrophy (Limited), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC4A7 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 44 | 48 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 3 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 44 | 8 | 0 |
Variants in SLC4A7
This is a list of pathogenic ClinVar variants found in the SLC4A7 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-27376828-C-G | not specified | Uncertain significance (Aug 27, 2024) | ||
3-27379241-A-G | SLC4A7-related disorder | Likely benign (Oct 15, 2019) | ||
3-27383181-G-T | not specified | Uncertain significance (Oct 06, 2021) | ||
3-27383241-G-A | not specified | Uncertain significance (Jan 09, 2024) | ||
3-27385912-T-C | not specified | Uncertain significance (Apr 20, 2023) | ||
3-27385974-T-G | not specified | Uncertain significance (Aug 01, 2022) | ||
3-27389957-C-G | not specified | Uncertain significance (Dec 09, 2023) | ||
3-27389997-C-G | not specified | Uncertain significance (Apr 20, 2023) | ||
3-27390040-C-T | not specified | Uncertain significance (Feb 28, 2024) | ||
3-27390047-A-G | not specified | Uncertain significance (Jul 07, 2022) | ||
3-27390094-C-T | not specified | Uncertain significance (Jun 04, 2024) | ||
3-27391797-C-T | not specified | Uncertain significance (Dec 28, 2023) | ||
3-27394592-G-A | not specified | Uncertain significance (Dec 18, 2023) | ||
3-27394659-A-C | not specified | Uncertain significance (Oct 12, 2021) | ||
3-27394726-A-G | not specified | Uncertain significance (Feb 17, 2022) | ||
3-27394730-C-T | not specified | Likely benign (Dec 14, 2022) | ||
3-27395024-C-T | not specified | Uncertain significance (Aug 04, 2022) | ||
3-27395072-T-A | not specified | Uncertain significance (Dec 26, 2023) | ||
3-27395104-T-C | SLC4A7-related disorder | Likely benign (Jun 24, 2019) | ||
3-27397743-T-C | not specified | Likely benign (Jul 06, 2022) | ||
3-27398285-A-G | SLC4A7-related disorder | Likely benign (Nov 19, 2019) | ||
3-27400861-C-A | not specified | Uncertain significance (Feb 22, 2023) | ||
3-27403167-T-C | not specified | Uncertain significance (Mar 19, 2024) | ||
3-27403173-T-C | not specified | Uncertain significance (Nov 30, 2022) | ||
3-27403274-G-C | not specified | Uncertain significance (May 21, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC4A7 | protein_coding | protein_coding | ENST00000295736 | 25 | 111698 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.736 | 0.264 | 125706 | 0 | 40 | 125746 | 0.000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.25 | 485 | 646 | 0.751 | 0.0000334 | 7919 |
Missense in Polyphen | 168 | 301.12 | 0.55791 | 3718 | ||
Synonymous | -0.662 | 235 | 222 | 1.06 | 0.0000114 | 2361 |
Loss of Function | 5.54 | 12 | 57.2 | 0.210 | 0.00000309 | 741 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000695 | 0.000691 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000111 | 0.000109 |
Finnish | 0.0000469 | 0.0000462 |
European (Non-Finnish) | 0.000162 | 0.000158 |
Middle Eastern | 0.000111 | 0.000109 |
South Asian | 0.000172 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Electroneutral sodium- and bicarbonate-dependent cotransporter with a Na(+):HCO3(-) 1:1 stoichiometry. Regulates intracellular pH and may play a role in bicarbonate salvage in secretory epithelia. May also have an associated sodium channel activity. {ECO:0000269|PubMed:10347222, ECO:0000269|PubMed:12403779}.;
- Pathway
- miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Transport of small molecules;Bicarbonate transporters
(Consensus)
Recessive Scores
- pRec
- 0.171
Intolerance Scores
- loftool
- 0.469
- rvis_EVS
- -0.97
- rvis_percentile_EVS
- 8.96
Haploinsufficiency Scores
- pHI
- 0.323
- hipred
- N
- hipred_score
- 0.476
- ghis
- 0.578
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.511
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc4a7
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; skeleton phenotype; vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Gene ontology
- Biological process
- sodium ion transport;inorganic anion transport;bicarbonate transport;regulation of intracellular pH;auditory receptor cell development;anion transmembrane transport
- Cellular component
- plasma membrane;integral component of plasma membrane;integral component of membrane;basolateral plasma membrane;apical plasma membrane;cytoplasmic vesicle;stereocilium;synapse
- Molecular function
- inorganic anion exchanger activity;sodium:bicarbonate symporter activity